>
Switch to:

Mednax PE Ratio

: 112.27 (As of Today)
View and export this data going back to 1959. Start your Free Trial

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2022-01-29), Mednax's share price is $24.70. Mednax's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.22. Therefore, Mednax's PE Ratio for today is 112.27.


The historical rank and industry rank for Mednax's PE Ratio or its related term are showing as below:

NYSE:MD' s PE Ratio Range Over the Past 10 Years
Min: 10.6   Med: 17.96   Max: 140.77
Current: 112.26

10.6
140.77

During the past 13 years, the highest PE Ratio of Mednax was 140.77. The lowest was 10.60. And the median was 17.96.


NYSE:MD's PE Ratio is ranked lower than
93% of the 377 Companies
in the Healthcare Providers & Services industry.

( Industry Median: 24.21 vs. NYSE:MD: 112.26 )

Mednax's Earnings per Share (Diluted) for the three months ended in Sep. 2021 was $0.36. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.22.

As of today (2022-01-29), Mednax's share price is $24.70. Mednax's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 was $0.84. Therefore, Mednax's PE Ratio without NRI for today is 29.40.

During the past 13 years, Mednax's highest PE Ratio without NRI was 200.63. The lowest was 9.34. And the median was 18.13.

Mednax's EPS without NRI for the three months ended in Sep. 2021 was $0.37. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 was $0.84.

During the past 12 months, Mednax's average EPS without NRI Growth Rate was 280.10% per year.

During the past 13 years, Mednax's highest 3-Year average EPS without NRI Growth Rate was 85.00% per year. The lowest was -47.70% per year. And the median was 13.90% per year.

Mednax's EPS (Basic) for the three months ended in Sep. 2021 was $0.36. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.23.


Mednax PE Ratio Historical Data

The historical data trend for Mednax's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mednax Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.10 15.49 11.26 At Loss At Loss

Mednax Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 129.23

Competitive Comparison

For the Medical Care Facilities subindustry, Mednax's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Mednax PE Ratio Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Mednax's PE Ratio distribution charts can be found below:

* The bar in red indicates where Mednax's PE Ratio falls into.



Mednax PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Mednax's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=24.70/0.220
=112.27

Mednax's Share Price of today is $24.70.
Mednax's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio or PE Ratio (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Mednax  (NYSE:MD) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Mednax PE Ratio Related Terms

Thank you for viewing the detailed overview of Mednax's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mednax Business Description

Mednax logo
Industry
Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Mednax Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. Mednax generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
Richards C Marc officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE SUITE 250-W BETHESDA MD 20814
Hinson Roger Mack officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC. 1301 CONCORD TERRACE SUNRISE FL 33323
Andreano Dominic J officer: EVP, General Counsel and Secy 1301 CONCORD TERRACE SUNRISE FL 33323
Nikolopoulos Nicholas officer: EVP Chf Strategy & Growth Offi MEDNAX INC 1301 SUNRISE FL 33323
Farber Stephen D officer: Former Chief Financial Officer 680 SOUTH FOURTH STREET LOUISVILLE KY 40202
Ordan Mark S director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE SUITE #250 WEST BETHESDA MD 20814
Starcher John M. Jr. director C/O HEALTH MANAGEMENT ASSOCIATES 5811 PELICAN BAY BOULEVARD, SUITE 500 NAPLES FL 34108
Sansone Guy P director C/O CIVITAS SOLUTIONS, INC. 313 CONGRESS STREET, 6TH FL BOSTON MA 02210
Weis Shirley A director 11621 RESEARCH CIRCLE GAINESVILLE FL 32615
Mceachin Thomas director 11621 RESEARCH CIRCLE ALACHUA FL 32615
Pepia John C officer: Principal Accounting Officer 1301 CONCORD TERRACE SUNRISE FL 33323
Medel Roger Md director, officer: Chief Executive Officer 1455 NORTH PARK DRIVE FORT LAUDERDALE FL 33326
Alvarez Cesar L director C/O PEDIATRIX MEDICAL GROUP LEGAL DEPT 1301- CONCORD TERRACE SUNRISE FL 33323
Goldschmidt, Md Pascal J director 1301 CONCORD TERRACE SUNRISE FL 33323
Kadre Manuel director CC1 COMPANIES, INC. 220 ALHAMBRA CIRCLE CORAL GABLES FL 33145

Mednax Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)